AngioDynamics Inc expected to post a loss of 1 cent a share - Earnings Preview

AngioDynamics

03/01/2023 13:44

* AngioDynamics Inc  ANGO.OQ   ANGO.O  is expected to show a
rise
in quarterly revenue when it reports  results on January 5. 
    * The Latham New York-based  company is expected to report 
a
7.7% increase in revenue to $84.33 million from $78.28 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AngioDynamics Inc
is for
a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $25.5​, above​ its last closing price of $13.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Aug. 31 2022  -0.02       -0.02      -0.06     Missed  -166.7
 May. 31 2022  0.01        0.01       0.01      Met     33.3
 Feb. 28 2022  -0.01       -0.01      0.03      Beat    340​
 Nov. 30 2021  0.00        0.01       -0.02     Missed  -481
 ​​Aug.        -0.04       -0.04      -0.02     Beat    55.6
 31 2021                                                
 May. 31 2021  0.00        0.00       0.00      Met     100​
 Feb. 28 2021  -0.03       -0.02      0.02      Beat    185.7
 Nov. 30 2020  -0.02       -0.02      0.01      Beat    150
 This summary was machine generated January 3 at 13:44 GMT.  All
figures in US dollars  unless otherwise stated